• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血小板反应蛋白-1和CD47调节血压及心脏对血管活性应激的反应。

Thrombospondin-1 and CD47 regulate blood pressure and cardiac responses to vasoactive stress.

作者信息

Isenberg Jeff S, Qin Yan, Maxhimer Justin B, Sipes John M, Despres Daryl, Schnermann Jurgen, Frazier William A, Roberts David D

机构信息

Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland 20892, United States.

出版信息

Matrix Biol. 2009 Mar;28(2):110-9. doi: 10.1016/j.matbio.2009.01.002. Epub 2009 Jan 21.

DOI:10.1016/j.matbio.2009.01.002
PMID:19284971
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2663008/
Abstract

Nitric oxide (NO) locally regulates vascular resistance and blood pressure by modulating blood vessel tone. Thrombospondin-1 signaling via its receptor CD47 locally limits the ability of NO to relax vascular smooth muscle cells and increase regional blood flow in ischemic tissues. To determine whether thrombospondin-1 plays a broader role in central cardiovascular physiology, we examined vasoactive stress responses in mice lacking thrombospondin-1 or CD47. Mice lacking thrombospondin-1 exhibit activity-associated increases in heart rate, central diastolic and mean arterial blood pressure and a constant decrease in pulse pressure. CD47-deficient mice have normal central pulse pressure but elevated resting peripheral blood pressure. Both null mice show exaggerated decreases in peripheral blood pressure and increased cardiac output and ejection fraction in response to NO. Autonomic blockade also induces exaggerated hypotensive responses in awake thrombospondin-1 null and CD47 null mice. Both null mice exhibit a greater hypotensive response to isoflurane, and autonomic blockage under isoflurane anesthesia leads to premature death of thrombospondin-1 null mice. Conversely, the hypertensive response to epinephrine is attenuated in thrombospondin-1 null mice. Thus, the matricellular protein thrombospondin-1 and its receptor CD47 serve as acute physiological regulators of blood pressure and exert a vasopressor activity to maintain global hemodynamics under stress.

摘要

一氧化氮(NO)通过调节血管张力局部调节血管阻力和血压。血小板反应蛋白-1通过其受体CD47发出的信号在局部限制了NO舒张血管平滑肌细胞及增加缺血组织局部血流量的能力。为了确定血小板反应蛋白-1在中枢心血管生理学中是否发挥更广泛的作用,我们检测了缺乏血小板反应蛋白-1或CD47的小鼠的血管活性应激反应。缺乏血小板反应蛋白-1的小鼠在活动时心率、中心舒张压和平均动脉血压升高,脉压持续降低。缺乏CD47的小鼠中心脉压正常,但静息外周血压升高。两种基因敲除小鼠对外周血压的降低反应均增强,对NO的反应中心输出量和射血分数增加。自主神经阻滞在清醒的血小板反应蛋白-1基因敲除和CD47基因敲除小鼠中也会引起过度的降压反应。两种基因敲除小鼠对异氟烷的降压反应均增强,异氟烷麻醉下的自主神经阻滞会导致血小板反应蛋白-1基因敲除小鼠过早死亡。相反,血小板反应蛋白-1基因敲除小鼠对肾上腺素的升压反应减弱。因此,基质细胞蛋白血小板反应蛋白-1及其受体CD47作为血压的急性生理调节因子,在应激状态下发挥血管升压活性以维持整体血流动力学。

相似文献

1
Thrombospondin-1 and CD47 regulate blood pressure and cardiac responses to vasoactive stress.血小板反应蛋白-1和CD47调节血压及心脏对血管活性应激的反应。
Matrix Biol. 2009 Mar;28(2):110-9. doi: 10.1016/j.matbio.2009.01.002. Epub 2009 Jan 21.
2
Age-associated induction of cell membrane CD47 limits basal and temperature-induced changes in cutaneous blood flow.年龄相关的细胞膜 CD47 诱导限制了皮肤血流的基础和温度诱导变化。
Ann Surg. 2013 Jul;258(1):184-91. doi: 10.1097/SLA.0b013e31827e52e1.
3
CD47 is necessary for inhibition of nitric oxide-stimulated vascular cell responses by thrombospondin-1.CD47对于血小板反应蛋白-1抑制一氧化氮刺激的血管细胞反应是必需的。
J Biol Chem. 2006 Sep 8;281(36):26069-80. doi: 10.1074/jbc.M605040200. Epub 2006 Jul 11.
4
Thrombospondin-1 inhibition of vascular smooth muscle cell responses occurs via modulation of both cAMP and cGMP.血小板反应蛋白-1 通过调节 cAMP 和 cGMP 抑制血管平滑肌细胞反应。
Pharmacol Res. 2011 Jan;63(1):13-22. doi: 10.1016/j.phrs.2010.10.014. Epub 2010 Oct 29.
5
Thrombospondin-1 and CD47 regulation of cardiac, pulmonary and vascular responses in health and disease.血小板反应蛋白-1与CD47对健康和疾病状态下心脏、肺及血管反应的调节作用
Matrix Biol. 2014 Jul;37:92-101. doi: 10.1016/j.matbio.2014.01.002. Epub 2014 Jan 11.
6
Blocking thrombospondin-1/CD47 signaling alleviates deleterious effects of aging on tissue responses to ischemia.阻断血小板反应蛋白-1/CD47信号通路可减轻衰老对组织缺血反应的有害影响。
Arterioscler Thromb Vasc Biol. 2007 Dec;27(12):2582-8. doi: 10.1161/ATVBAHA.107.155390. Epub 2007 Oct 4.
7
Differential interactions of thrombospondin-1, -2, and -4 with CD47 and effects on cGMP signaling and ischemic injury responses.血小板反应蛋白-1、-2和-4与CD47的差异相互作用及其对环磷酸鸟苷信号传导和缺血性损伤反应的影响。
J Biol Chem. 2009 Jan 9;284(2):1116-25. doi: 10.1074/jbc.M804860200. Epub 2008 Nov 11.
8
Enhancing cardiovascular dynamics by inhibition of thrombospondin-1/CD47 signaling.通过抑制血小板反应蛋白-1/CD47信号传导增强心血管动力学。
Curr Drug Targets. 2008 Oct;9(10):833-41. doi: 10.2174/138945008785909338.
9
Thrombospondin-1 and CD47 limit cell and tissue survival of radiation injury.血小板反应蛋白-1和CD47限制辐射损伤的细胞和组织存活。
Am J Pathol. 2008 Oct;173(4):1100-12. doi: 10.2353/ajpath.2008.080237. Epub 2008 Sep 11.
10
Thrombospondin-1-CD47 blockade and exogenous nitrite enhance ischemic tissue survival, blood flow and angiogenesis via coupled NO-cGMP pathway activation.血小板反应蛋白-1- CD47阻断和外源性亚硝酸盐通过耦合的NO - cGMP途径激活增强缺血组织的存活、血流和血管生成。
Nitric Oxide. 2009 Aug;21(1):52-62. doi: 10.1016/j.niox.2009.05.005. Epub 2009 May 27.

引用本文的文献

1
The mechanobiology of extracellular matrix: a focus on thrombospondins.细胞外基质的机械生物学:聚焦血小板反应蛋白
Cell Commun Signal. 2025 Jul 25;23(1):354. doi: 10.1186/s12964-025-02365-y.
2
THBS1 mediates hypoxia driven EndMT in pulmonary hypertension.血小板反应蛋白1(THBS1)介导缺氧驱动的肺动脉高压中的内皮-间充质转化(EndMT)。
Pulm Circ. 2024 Dec 4;14(4):e70019. doi: 10.1002/pul2.70019. eCollection 2024 Oct.
3
Tolerating CD47.耐受 CD47.
Clin Transl Med. 2024 Feb;14(2):e1584. doi: 10.1002/ctm2.1584.
4
Serum multi-omics analysis in hindlimb unloading mice model: Insights into systemic molecular changes and potential diagnostic and therapeutic biomarkers.后肢卸载小鼠模型中的血清多组学分析:对全身分子变化以及潜在诊断和治疗生物标志物的见解
Heliyon. 2023 Dec 12;10(1):e23592. doi: 10.1016/j.heliyon.2023.e23592. eCollection 2024 Jan 15.
5
Matricellular proteins in atherosclerosis development.细胞基质蛋白在动脉粥样硬化发展中的作用。
Matrix Biol. 2023 Jun;120:1-23. doi: 10.1016/j.matbio.2023.04.003. Epub 2023 Apr 20.
6
Emerging phagocytosis checkpoints in cancer immunotherapy.癌症免疫治疗中的新兴吞噬检查点。
Signal Transduct Target Ther. 2023 Mar 7;8(1):104. doi: 10.1038/s41392-023-01365-z.
7
CD47 antisense oligonucleotide treatment attenuates obesity and its-associated metabolic dysfunction.CD47 反义寡核苷酸治疗可减轻肥胖及其相关代谢功能障碍。
Sci Rep. 2023 Feb 16;13(1):2748. doi: 10.1038/s41598-023-30006-2.
8
Cabozantinib, Vandetanib, Pralsetinib and Selpercatinib as Treatment for Progressed Medullary Thyroid Cancer with a Main Focus on Hypertension as Adverse Effect.卡博替尼、凡德他尼、普拉替尼和塞尔帕替尼治疗进展性甲状腺髓样癌,重点关注高血压作为不良反应。
Int J Mol Sci. 2023 Jan 24;24(3):2312. doi: 10.3390/ijms24032312.
9
Why do humans need thrombospondin-1?人类为什么需要血小板反应蛋白-1?
J Cell Commun Signal. 2023 Sep;17(3):485-493. doi: 10.1007/s12079-023-00722-5. Epub 2023 Jan 23.
10
Macrophages in myocardial infarction.心肌梗死中的巨噬细胞。
Am J Physiol Cell Physiol. 2022 Oct 1;323(4):C1304-C1324. doi: 10.1152/ajpcell.00230.2022. Epub 2022 Sep 12.

本文引用的文献

1
Differential interactions of thrombospondin-1, -2, and -4 with CD47 and effects on cGMP signaling and ischemic injury responses.血小板反应蛋白-1、-2和-4与CD47的差异相互作用及其对环磷酸鸟苷信号传导和缺血性损伤反应的影响。
J Biol Chem. 2009 Jan 9;284(2):1116-25. doi: 10.1074/jbc.M804860200. Epub 2008 Nov 11.
2
Elastin insufficiency predisposes to elevated pulmonary circulatory pressures through changes in elastic artery structure.弹性蛋白缺乏通过弹性动脉结构的改变,易导致肺循环压力升高。
J Appl Physiol (1985). 2008 Nov;105(5):1610-9. doi: 10.1152/japplphysiol.90563.2008. Epub 2008 Sep 4.
3
Novel structural determinants on SIRP alpha that mediate binding to CD47.信号调节蛋白α(SIRPα)上介导与CD47结合的新型结构决定簇。
J Immunol. 2007 Dec 1;179(11):7741-50. doi: 10.4049/jimmunol.179.11.7741.
4
Blocking thrombospondin-1/CD47 signaling alleviates deleterious effects of aging on tissue responses to ischemia.阻断血小板反应蛋白-1/CD47信号通路可减轻衰老对组织缺血反应的有害影响。
Arterioscler Thromb Vasc Biol. 2007 Dec;27(12):2582-8. doi: 10.1161/ATVBAHA.107.155390. Epub 2007 Oct 4.
5
Thrombospondin-1 stimulates platelet aggregation by blocking the antithrombotic activity of nitric oxide/cGMP signaling.血小板反应蛋白-1通过阻断一氧化氮/cGMP信号通路的抗血栓形成活性来刺激血小板聚集。
Blood. 2008 Jan 15;111(2):613-23. doi: 10.1182/blood-2007-06-098392. Epub 2007 Sep 21.
6
Management of complications during moderate and deep sedation: respiratory and cardiovascular considerations.中度和深度镇静期间并发症的管理:呼吸与心血管方面的考量
Anesth Prog. 2007 Summer;54(2):59-68; quiz 69. doi: 10.2344/0003-3006(2007)54[59:MOCDMA]2.0.CO;2.
7
cAMP and cGMP signaling cross-talk: role of phosphodiesterases and implications for cardiac pathophysiology.环磷酸腺苷(cAMP)与环磷酸鸟苷(cGMP)信号转导的相互作用:磷酸二酯酶的作用及其对心脏病理生理学的影响
Circ Res. 2007 Jun 8;100(11):1569-78. doi: 10.1161/CIRCRESAHA.106.144501.
8
Norepinephrine transporter blockade with atomoxetine induces hypertension in patients with impaired autonomic function.用托莫西汀阻断去甲肾上腺素转运体可导致自主神经功能受损患者出现高血压。
Hypertension. 2007 Jul;50(1):47-53. doi: 10.1161/HYPERTENSIONAHA.107.089961. Epub 2007 May 21.
9
Interactions between CD47 and thrombospondin reduce inflammation.CD47与血小板反应蛋白之间的相互作用可减轻炎症。
J Immunol. 2007 May 1;178(9):5930-9. doi: 10.4049/jimmunol.178.9.5930.
10
Elastin-insufficient mice show normal cardiovascular remodeling in 2K1C hypertension despite higher baseline pressure and unique cardiovascular architecture.弹性蛋白不足的小鼠在二肾一夹(2K1C)高血压模型中表现出正常的心血管重塑,尽管其基线血压较高且具有独特的心血管结构。
Am J Physiol Heart Circ Physiol. 2007 Jul;293(1):H574-82. doi: 10.1152/ajpheart.00205.2007. Epub 2007 Mar 30.